Skip to main content
Apply for Grants

Funding Opportunities

The Michael J. Fox Foundation works tirelessly to accelerate promising research toward breakthroughs for people with Parkinson's.

Our funding programs support basic, translational and clinical research from academia and industry. In addition to funding, awardees benefit from working with our internal research staff and broad network of scientific and industry advisors.

Browse Funding Opportunities

Open Programs

  • ASAP Collaborative Research Network
    ASAP logo
    Objective:
    The ASAP Collaborative Research Network, a program of the Aligning Science Across Parkinson’s (ASAP) initiative being implemented through The Michael J. Fox Foundation, seeks to support international, multidisciplinary, multi-institutional research teams to address key knowledge gaps in the basic disease mechanisms that contribute to Parkinson’s development and progression.
  • Ken Griffin Alpha-synuclein Imaging Competition
    Ken Griffin Alpha-synuclein Imaging Competition Logo
    Objective:
    The Michael J. Fox Foundation has prioritized alpha-synuclein imaging as the most likely imaging approach to have an impact for therapeutic development. The goal of this $10-million funding program is to deliver a selective alpha-synuclein PET tracer for use in clinical studies.
  • The Edmond J. Safra Fellowship in Movement Disorders
    Objective:
    Movement disorder specialists (neurologists with subspecialty training in Parkinson's disease and other movement disorders) serve as an important bridge between scientific advances in the lab and positive patient outcomes in the care setting.

Programs in Review

  • Therapeutic Pipeline Program
    Objective:
    The Michael J. Fox Foundation seeks applications with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care.
  • Use of Parkinson’s Disease Biosamples
    Objective:
    The Michael J. Fox Foundation seeks to facilitate access and use of our cohort biosamples. Applicants can request these human biosamples and associated grant funding for target validation or biomarker development programs.
  • CLIA Lab for Genetic Testing RFP
    Objective:
    We are seeking a CLIA laboratory to conduct genetic testing on samples from people who may carry a Parkinson's-related mutation.
  • Biology of Astrocytes in Parkinson’s Disease
    Objective:
    The Michael J. Fox Foundation will award one-year to 18-month grants for studies that explore the role of astrocytes in Parkinson’s disease (PD) pathology and the potential for astrocyte-focused therapeutics. The goals of this funding program are to further understanding of astrocyte biology in Parkinson’s and to rationalize the pursuit of astrocyte-specific targets and/or pathways for the treatment of the disease.
  • Assay Development and Validation for Quantifying Oligomeric Alpha-Synuclein
    Objective:
    The Michael J. Fox Foundation will award one-year grants for research to advance the development, optimization and validation of assays to quantify oligomeric alpha-synuclein in human body fluids. Prior research suggests that alpha-synuclein quantification in accessible body fluids may serve as a biomarker of disease diagnosis, target engagement, pharmacodynamic response and/or patient stratification.
  • Imaging Biomarkers to Track Disease Progression and Therapeutic Efficacy
    Objective:
    The Michael J. Fox Foundation will award one- to three-year grants to develop imaging markers for use in disease-modifying clinical trials. Imaging is a powerful tool that can be used to visualize the structure and function of the brain in living subjects. While a variety of imaging techniques are available, none have been demonstrated to be a sensitive, specific and reliable biomarker test for the presence and progression of PD.
  • Therapeutic Pipeline Program
    Objective:
    The Michael J. Fox Foundation seeks applications with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care. The Therapeutic Pipeline Program is an Edmond J. Safra Core Program for PD Research.
  • Illustrated avatar with check mark.

    Grant Portal

    View submitted or in progress applications.

  • Illustrated envelope containing alert message.

    Funding Alerts

    Sign up for email updates on resources and initiatives to accelerate research and to improve Parkinson's care.

  • Illustrated series of test tubes.

    Application Guidelines

    Our funding application guidelines cover our review process and criteria, confidentiality, conflicts of interest, and special requirements. 

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.